Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
National Healthcare Properties Q1 2026 Earnings Call - IPO Fuelled Strategic Pivot to Senior Housing with $528M OMF Sale
National Healthcare Properties entered the public markets in April 2026 with a $531 million IPO, immediately using the proceeds to retire $186 million in debt and strengthen its balance sheet. The com...
- National Healthcare Properties completed its IPO in April 2026, raising $531 million, which was primarily used to repay $186 million in debt, strengthening the balance sheet at the start of its public tenure.
- The company announced a $528.2 million sale of 86 outpatient medical facilities (OMF), marking a strategic pivot to concentrate capital in senior housing, the asset class with the strongest growth conviction.
- SHOP same-store cash NOI surged 24% year-over-year in Q1 2026, driven by occupancy recovery, rate growth, and improving operating leverage.
- +7 more takeaways
Global Water Resources Inc. Q1 2026 Earnings Call - Rate Case Settlement Clears Path for Future Growth Despite Near-Term Earnings Pressure
Global Water Resources reported a $0.4 million net loss in Q1 2026, a sharp reversal from last year’s profit, driven by heavy depreciation and operating costs tied to the recent recommissioning of its...
- Q1 2026 net loss of $0.4 million ($0.01 per diluted share) reverses Q1 2025 net income of $0.6 million ($0.02 per diluted share).
- Total revenue rose 6.7% to $13.3 million, driven by the July 2025 acquisition of seven Tucson Water systems, organic connection growth, and higher rates in the GW Farmer utility.
- Operating expenses jumped 15.1% to $12.9 million, with depreciation, amortization, and accretion up $0.9 million due to the Southwest Plant recommissioning and other 2025 capital projects.
- +7 more takeaways
South Bow Q1 2026 Earnings Call - Prairie Connector Evaluation and Keystone Integrity Progress
South Bow delivered solid first-quarter 2026 results, with normalized EBITDA of $257 million in line with expectations and distributable cash flow rising to $168 million. The company reaffirmed its fu...
- Normalized EBITDA of $257 million in Q1 2026 met market expectations and was modestly higher than Q4 2025, driven by strong marketing segment contributions that offset lower Keystone maintenance activity.
- South Bow reaffirmed its full-year normalized EBITDA guidance of $1.03 billion within a 2% range, with any potential marketing upside expected to remain within this band.
- Distributable cash flow rose to $168 million quarter-over-quarter, supported by lower current taxes, while the company maintained its full-year DCF outlook of $655 million to fund dividends and balance sheet strength.
- +7 more takeaways
ALX Oncology Q1 2026 Earnings Call - CD47 Biomarker Drives Durable Responses in Heavily Pretreated HER2-Positive Breast Cancer
ALX Oncology reported Q1 2026 results highlighting new data from an ESMO Breast Cancer presentation showing evorpacept combined with zanidatamab produces durable clinical responses in heavily pretreat...
- Evorpacept combined with zanidatamab achieved a 33% confirmed objective response rate in 24 patients with heavily pretreated HER2-positive metastatic breast cancer, including one complete response.
- CD47 overexpression (≥20% membrane staining) emerged as a strong predictive biomarker, with all five HER2-positive and CD47-high patients responding and a median progression-free survival of 22 months versus 3.4 months in CD47-low patients.
- Median duration of response reached 20 months in responding patients, demonstrating durable clinical benefit consistent with immune-mediated mechanisms of action.
- +7 more takeaways
Plains All American Pipeline Q1 2026 Earnings Call - Raising 2026 EBITDA Guidance Amid Middle East Supply Disruptions
Plains All American Pipeline (PAA) delivered a robust first quarter 2026, reporting adjusted EBITDA of $730 million and upgrading full-year guidance by $130 million to a $2.88 billion midpoint. Manage...
- Q1 2026 adjusted EBITDA reached $730 million, supported by full-quarter Cactus III contribution and strong NGL straddle production.
- Full-year 2026 adjusted EBITDA guidance raised by $130 million to a $2.88 billion midpoint, driven by NGL outperformance and crude optimization captures.
- NGL segment EBITDA guidance increased by $70 million to $170 million, reflecting higher border flows and improved frac spreads; divestiture now targeted for May 2026.
- +7 more takeaways
Wendy's Q1 2026 Earnings Call - Project Fresh Turnaround Faces Headwinds as U.S. Sales Decline 7.8%
Wendy's Q1 2026 results underscore a company navigating a difficult competitive landscape while executing the early stages of its Project Fresh turnaround strategy. Global system-wide sales declined 5...
- Global system-wide sales declined 5.5% in Q1 2026, with U.S. same-restaurant sales falling 7.8% due to traffic declines, severe weather, and operating hour optimizations.
- International system-wide sales grew 6%, driven by net unit growth in key markets like the Philippines and Mexico, offsetting U.S. softness.
- Wendy's signed a landmark franchise agreement to open up to 1,000 restaurants in China over the next 10 years, marking the largest development deal in the company's history.
- +7 more takeaways
Mettler-Toledo Q1 2026 Earnings Call - EPS Growth Holds Steady Amid Geopolitical Uncertainty and Tariff Headwinds
Mettler-Toledo delivered solid Q1 2026 results with adjusted EPS of $8.91, up 9% year-over-year, driven by disciplined margin expansion and strong service revenue growth. The company navigated a turbu...
- Adjusted EPS of $8.91 grew 9% year-over-year, exceeding guidance and offsetting a 4% tariff headwind through pricing power and cost discipline.
- Local currency sales grew 3% ($947M), with industrial up 5% and product inspection up 11%, while laboratory sales remained flat due to academia and biotech softness.
- Service revenue grew 7% organically, reinforcing the recurring revenue model and high attach rates in automated inspection segments.
- +7 more takeaways
LENSAR Q1 2026 Earnings Call - Recurring Revenue Growth Offsets System Sales Slump as LENSAR Rebuilds Post-Alcon Split
LENSAR exited a year-long holding pattern following the termination of its merger with Alcon, emerging as an independent company focused on rebuilding its core business. The first quarter of 2026 saw ...
- LENSAR terminated its merger with Alcon in mid-March 2026, ending a year-long strategic limbo and allowing the company to operate as an independent entity again.
- Total revenue for Q1 2026 was $13.4 million, a 5% decline from $14.2 million in Q1 2025, primarily due to lower system capital sales.
- Recurring revenue grew 9% year-over-year to $12.6 million, now representing 94% of total revenue and signaling a shift toward a more durable, subscription-like business model.
- +12 more takeaways
Burford Capital Q1 2026 Earnings Call - Core Business Cash Generation Outweighs YPF Setback
Burford Capital’s Q1 2026 results are dominated by a non-cash write-down from the YPF litigation loss, but the company insists the core business remains a cash-generating powerhouse. CEO Christopher B...
- Burford Capital takes a substantial non-cash write-down on YPF after a 2-1 Second Circuit reversal, but CEO Christopher Bogart stresses the investment remains a cash-profitable event with over $100M in realized cash proceeds since inception.
- The company will pursue international arbitration against Argentina, citing an 86% pro-investor resolution rate in bilateral investment treaty cases against the country, with expected costs in the $10M-$20M range.
- Core business momentum is accelerating: $133M in new definitive commitments in Q1 2026, up 25% year-over-year, with $1B in undrawn definitive commitments and $600M in discretionary commitments ready to deploy.
- +7 more takeaways
Goldman Sachs BDC Q1 2026 Earnings Call - Legacy Portfolio Drag Masks Strong New Vintage Performance
Goldman Sachs BDC reported a challenging first quarter, with net investment income per share falling to $0.22 and net asset value declining 3.7% to $12.17. The drag came almost entirely from the legac...
- Net investment income per share fell to $0.22, down from prior quarters, driven by higher incentive fee accruals and unrealized losses on legacy assets.
- Net asset value per share declined 3.7% to $12.17, primarily due to mark-to-market adjustments on older portfolio positions rather than new credit deterioration.
- The legacy portfolio (pre-2022 vintages) represents 42% of the book but generated 72% of quarterly losses and over 99.5% of non-accruals at cost.
- +7 more takeaways